Houben Healthcare Consultancy was founded by Remco Houben early 2017.
Remco’s roots are in former N.V. Organon which was taken over by Schering-Plough and later on by Merck / MSD. In these large pharma companies he held several positions within Global Drug Safety / Pharmacovigilance (PV) thereby comprising most aspects of PV including case processing, literature screening, aggregate report writing, signal detection / assessment and risk management. After working in the pharmacovigilance pharma industry for 8 years, Remco provided regulatory and pharmacovigilance support to multiple clients in the pharma industry as part of two consultancy organisations. After being a consultant for almost 4 years, Remco joined Astellas where he acted as a global medical safety manager for 2 years. Thereafter, he founded Houben Healthcare Consultancy and started working as a freelance consultant.
Throughout his career Remco has collaborated closely with other functions such as Clinical, Pharmacoepidemiology, Regulatory and Medical Affairs and he has grown (hands-on) experience in numerous therapeutic areas and products types. Through his multi-disciplinary background in different (large) pharma companies and consultancy organisations, Remco has gained a deep understanding of regulatory requirements (including ICH guidelines and GVP modules) and developed a unique blend of operational and scientific (writing) skills and holistic understanding of the science and challenges faced in deploying a successful Pharmacovigilance System. Remco can support on different levels ranging from operational to strategic.